- Home
- SKYH vs RCKT Comparison
SKYH vs RCKT Comparison
Compare SKYH & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SKYH | RCKT |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 324.6M | 340.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SKYH | RCKT |
|---|---|---|
| Price | $9.25 | $3.49 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 14 |
| Target Price | $13.83 | ★ $29.12 |
| AVG Volume (30 Days) | 140.7K | ★ 2.3M |
| Earning Date | 11-12-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $24,125,000.00 | N/A |
| Revenue This Year | $95.10 | N/A |
| Revenue Next Year | $71.21 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 95.23 | N/A |
| 52 Week Low | $8.22 | $2.19 |
| 52 Week High | $14.20 | $13.50 |
Technical Indicators
Market Signals| Indicator | SKYH | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 47.17 | 54.06 |
| Support Level | $9.39 | $3.30 |
| Resistance Level | $10.07 | $3.65 |
| Average True Range (ATR) | 0.38 | 0.19 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 58.43 | 73.88 |
Price Performance
Historical ComparisonAbout SKYH Sky Harbour Group Corporation
Sky Harbour Group Corp is an aviation infrastructure company building a nationwide network of Home-based solutions for business aircraft. The company develops, leases, and manages business aviation hangars across the United States based on its proprietary targeting and acquisition model, targeting airfields with hangar supply and demand imbalances in the markets. Its hangar campuses feature exclusive private hangars and a full suite of dedicated services specifically designed for home-based aircraft.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.